Gotta say I'm a bit surprised that some here seem to be looking...

Gotta say I'm a bit surprised that some here seem to be looking down their noses at Otto. You do realise that back in July last year Otto bought 25m RHY shares at 6 cents a pop. As of today that 6 cents a share has bloomed into $1.58 and Otto is sitting on a $38m paper profit. Now you might argue, well he just got lucky. The thing is, when it comes to spec stocks it is always better to be lucky than good.

Also the technical director at Rhythm, Trevor Lockett, saw Rhythm's first product right through development at CSIRO to setting up Rhythm as a listed company to now looking for the next product line for the company. Rhythm only needs one boffin on the board when that boffin has the smarts like TL.

If you think Oncosil actually has something to offer then I suggest you give Otto some time - rule of thumb is 6 months - to get the company pointing in the right direction.